IPP Bureau
Sumitomo Pharma unveils new COURAGE & OPTYX data at AUA 2026
By IPP Bureau - May 25, 2026
Highlights strong Vibegron results in older men & real-world prostate cancer insights
Enveric reports key safety milestone for EB-003 reinforcing clinical development path
By IPP Bureau - May 25, 2026
The findings support the continued advancement of EB-003, a first-in-class neuroplastogen designed to selectively target both 5-HT2A and 5-HT1B receptors
Maxivision appoints Surya K as Group Head – Medical Affairs and Quality
By IPP Bureau - May 23, 2026
Surya to lead medical governance, patient safety, clinical excellence, and quality assurance initiatives across the organization’s pan-India network.
Shreevar Kheruka appointed Managing Director at Borosil Limited
By IPP Bureau - May 23, 2026
Kheruka has played a key role in transforming Borosil into a diversified, international consumer-focused enterprise
Fortis Healthcare FY26 revenue crosses Rs. 9,100 crore
By IPP Bureau - May 23, 2026
Q4 FY26 PAT jumps 44% to Rs. 271 crore, supported by acquisitions, specialty expansion, and diagnostics momentum
Merck doses first patient in Phase 3 trial of novel antibody-drug conjugate for metastatic colorectal cancer
By IPP Bureau - May 23, 2026
The trial will assess Precem-TcT, both as monotherapy and in combination with bevacizumab, in patients whose disease has progressed after or become resistant to standard treatments
Eli lilly’s retatrutide delivers up to 30% weight loss in phase 3 trial
By IPP Bureau - May 23, 2026
Clears major obesity endpoints at 80 weeks
Health ministry classifies Pregabalin under Schedule H1 to curb misuse
By IPP Bureau - May 23, 2026
New regulation mandates stricter prescription monitoring, sales record maintenance, and enhanced compliance across the pharmaceutical supply chain
ZIM Laboratories wins European regulatory milestone with anticoagulant approval in Italy
By IPP Bureau - May 23, 2026
The approval was granted by Agenzia Italiana del Farmaco
WACKER launches contract research services to accelerate next-gen RNA & DNA therapies
By IPP Bureau - May 23, 2026
The new CRS offering is delivered from WACKER’s Biotechnology Center in Munich
Gujarat Themis Biosyn acquires MicroBiopharm Japan for Rs. 1,300 Cr
By IPP Bureau - May 23, 2026
Transition to a fermentation-based globally integrated CDMO platform
ABDM crosses 100 crore ABHA-linked health records milestone
By IPP Bureau - May 23, 2026
More than 450 public and private health technology solutions have integrated with the Ayushman Bharat Digital Mission ecosystem
OncoSil secures TGA approval for pancreatic cancer device
By IPP Bureau - May 22, 2026
Approval of device in Australia for treating locally advanced pancreatic cancer alongside gemcitabine-based chemotherapy
Eli Lilly appoints Chandan S. as Senior Director for Data Science and AI Engineering
By IPP Bureau - May 22, 2026
AI and analytics leader brings extensive expertise in machine learning, GenAI, and life sciences decision intelligence to Lilly’s data science operations
Alembic Pharma elevates Karunanithi Ponnusamy as President of Animal Health Business
By IPP Bureau - May 22, 2026
Pharma veteran with over three decades of industry experience to lead Alembic’s animal health growth and market expansion initiatives.
